Secondary outcomes
vessel occlusion
Secondary efficacy outcomes in this analysis included 90‐day mRS score of 0–1, and 90‐day distribution of mRS scores. As presented in Table Distribution of the modified Rankin Scale (mRS) scores at 90 days. The distributions of the mRS score among patients with large vessel occlusion were presented according to the trichotomized SHR (